Found 11 hits Enz. Inhib. hit(s) with Target = 'Coagulation factor XI' and Ligand = 'BDBM246249' Target/Host
(Institution) | Ligand | Target/Host
Links | Ligand
Links | Trg + Lig
Links | Ki
nM | ΔG°
kJ/mole | IC50
nM | Kd
nM | EC50/IC50
nM | koff
s-1 | kon
M-1s-1 | pH | Temp
°C |
|---|
Coagulation factor XI
(Homo sapiens (Human)) | BDBM246249
(US10183932, Example 157 | US9434690, 155 | US94346...)Show SMILES CO[C@H]1CC[C@H](CC(C(=O)Nc2ccc(cc2)C(O)=O)n2cc(OC)c(cc2=O)-c2cc(Cl)ccc2C#N)CC1 |r,wU:2.1,wD:5.5,(6.67,4.62,;5.33,5.39,;4,4.62,;4,3.08,;2.67,2.31,;1.33,3.08,;,2.31,;,.77,;1.33,,;1.33,-1.54,;2.67,.77,;4,,;4,-1.54,;5.33,-2.31,;6.67,-1.54,;6.67,,;5.33,.77,;8,-2.31,;9.34,-1.54,;8,-3.85,;-1.33,,;-2.67,.77,;-4,,;-5.33,.77,;-6.67,,;-4,-1.54,;-2.67,-2.31,;-1.33,-1.54,;,-2.31,;-5.33,-2.31,;-6.67,-1.54,;-8,-2.31,;-9.34,-1.54,;-8,-3.85,;-6.67,-4.62,;-5.33,-3.85,;-4,-4.62,;-2.67,-5.39,;1.33,4.62,;2.67,5.39,)| Show InChI InChI=1S/C30H30ClN3O6/c1-39-23-11-3-18(4-12-23)13-26(29(36)33-22-9-6-19(7-10-22)30(37)38)34-17-27(40-2)25(15-28(34)35)24-14-21(31)8-5-20(24)16-32/h5-10,14-15,17-18,23,26H,3-4,11-13H2,1-2H3,(H,33,36)(H,37,38)/t18-,23-,26? | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 0.800 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft
US Patent
| Assay Description
To determine the factor XIa inhibition of the substances according to the invention, a biochemical test system is used which utilizes the reaction of... |
US Patent US10183932 (2019)
BindingDB Entry DOI: 10.7270/Q23T9K99 |
More data for this
Ligand-Target Pair | |
Coagulation factor XI
(Homo sapiens (Human)) | BDBM246249
(US10183932, Example 157 | US9434690, 155 | US94346...)Show SMILES CO[C@H]1CC[C@H](CC(C(=O)Nc2ccc(cc2)C(O)=O)n2cc(OC)c(cc2=O)-c2cc(Cl)ccc2C#N)CC1 |r,wU:2.1,wD:5.5,(6.67,4.62,;5.33,5.39,;4,4.62,;4,3.08,;2.67,2.31,;1.33,3.08,;,2.31,;,.77,;1.33,,;1.33,-1.54,;2.67,.77,;4,,;4,-1.54,;5.33,-2.31,;6.67,-1.54,;6.67,,;5.33,.77,;8,-2.31,;9.34,-1.54,;8,-3.85,;-1.33,,;-2.67,.77,;-4,,;-5.33,.77,;-6.67,,;-4,-1.54,;-2.67,-2.31,;-1.33,-1.54,;,-2.31,;-5.33,-2.31,;-6.67,-1.54,;-8,-2.31,;-9.34,-1.54,;-8,-3.85,;-6.67,-4.62,;-5.33,-3.85,;-4,-4.62,;-2.67,-5.39,;1.33,4.62,;2.67,5.39,)| Show InChI InChI=1S/C30H30ClN3O6/c1-39-23-11-3-18(4-12-23)13-26(29(36)33-22-9-6-19(7-10-22)30(37)38)34-17-27(40-2)25(15-28(34)35)24-14-21(31)8-5-20(24)16-32/h5-10,14-15,17-18,23,26H,3-4,11-13H2,1-2H3,(H,33,36)(H,37,38)/t18-,23-,26? | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 0.800 | n/a | n/a | n/a | n/a | n/a | n/a |
BAYER PHARMA AKTIENGESELLSCHAFT
US Patent
| Assay Description
Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000 μM to 0.0078 μM; resulting final con... |
US Patent US9822102 (2017)
BindingDB Entry DOI: 10.7270/Q2FN18G5 |
More data for this
Ligand-Target Pair | |
Coagulation factor XI
(Homo sapiens (Human)) | BDBM246249
(US10183932, Example 157 | US9434690, 155 | US94346...)Show SMILES CO[C@H]1CC[C@H](CC(C(=O)Nc2ccc(cc2)C(O)=O)n2cc(OC)c(cc2=O)-c2cc(Cl)ccc2C#N)CC1 |r,wU:2.1,wD:5.5,(6.67,4.62,;5.33,5.39,;4,4.62,;4,3.08,;2.67,2.31,;1.33,3.08,;,2.31,;,.77,;1.33,,;1.33,-1.54,;2.67,.77,;4,,;4,-1.54,;5.33,-2.31,;6.67,-1.54,;6.67,,;5.33,.77,;8,-2.31,;9.34,-1.54,;8,-3.85,;-1.33,,;-2.67,.77,;-4,,;-5.33,.77,;-6.67,,;-4,-1.54,;-2.67,-2.31,;-1.33,-1.54,;,-2.31,;-5.33,-2.31,;-6.67,-1.54,;-8,-2.31,;-9.34,-1.54,;-8,-3.85,;-6.67,-4.62,;-5.33,-3.85,;-4,-4.62,;-2.67,-5.39,;1.33,4.62,;2.67,5.39,)| Show InChI InChI=1S/C30H30ClN3O6/c1-39-23-11-3-18(4-12-23)13-26(29(36)33-22-9-6-19(7-10-22)30(37)38)34-17-27(40-2)25(15-28(34)35)24-14-21(31)8-5-20(24)16-32/h5-10,14-15,17-18,23,26H,3-4,11-13H2,1-2H3,(H,33,36)(H,37,38)/t18-,23-,26? | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 0.800 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Bayer Pharma Aktiengesellschaft
US Patent
| Assay Description
Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000 μM to 0.0078 μM; resulting final con... |
US Patent US9434690 (2016)
BindingDB Entry DOI: 10.7270/Q2K936FF |
More data for this
Ligand-Target Pair | |
Coagulation factor XI
(Homo sapiens (Human)) | BDBM246249
(US10183932, Example 157 | US9434690, 155 | US94346...)Show SMILES CO[C@H]1CC[C@H](CC(C(=O)Nc2ccc(cc2)C(O)=O)n2cc(OC)c(cc2=O)-c2cc(Cl)ccc2C#N)CC1 |r,wU:2.1,wD:5.5,(6.67,4.62,;5.33,5.39,;4,4.62,;4,3.08,;2.67,2.31,;1.33,3.08,;,2.31,;,.77,;1.33,,;1.33,-1.54,;2.67,.77,;4,,;4,-1.54,;5.33,-2.31,;6.67,-1.54,;6.67,,;5.33,.77,;8,-2.31,;9.34,-1.54,;8,-3.85,;-1.33,,;-2.67,.77,;-4,,;-5.33,.77,;-6.67,,;-4,-1.54,;-2.67,-2.31,;-1.33,-1.54,;,-2.31,;-5.33,-2.31,;-6.67,-1.54,;-8,-2.31,;-9.34,-1.54,;-8,-3.85,;-6.67,-4.62,;-5.33,-3.85,;-4,-4.62,;-2.67,-5.39,;1.33,4.62,;2.67,5.39,)| Show InChI InChI=1S/C30H30ClN3O6/c1-39-23-11-3-18(4-12-23)13-26(29(36)33-22-9-6-19(7-10-22)30(37)38)34-17-27(40-2)25(15-28(34)35)24-14-21(31)8-5-20(24)16-32/h5-10,14-15,17-18,23,26H,3-4,11-13H2,1-2H3,(H,33,36)(H,37,38)/t18-,23-,26? | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft
US Patent
| Assay Description
To determine the factor XIa inhibition of the substances according to the invention, a biochemical test system is used which utilizes the reaction of... |
US Patent US10183932 (2019)
BindingDB Entry DOI: 10.7270/Q23T9K99 |
More data for this
Ligand-Target Pair | |
Coagulation factor XI
(Homo sapiens (Human)) | BDBM246249
(US10183932, Example 157 | US9434690, 155 | US94346...)Show SMILES CO[C@H]1CC[C@H](CC(C(=O)Nc2ccc(cc2)C(O)=O)n2cc(OC)c(cc2=O)-c2cc(Cl)ccc2C#N)CC1 |r,wU:2.1,wD:5.5,(6.67,4.62,;5.33,5.39,;4,4.62,;4,3.08,;2.67,2.31,;1.33,3.08,;,2.31,;,.77,;1.33,,;1.33,-1.54,;2.67,.77,;4,,;4,-1.54,;5.33,-2.31,;6.67,-1.54,;6.67,,;5.33,.77,;8,-2.31,;9.34,-1.54,;8,-3.85,;-1.33,,;-2.67,.77,;-4,,;-5.33,.77,;-6.67,,;-4,-1.54,;-2.67,-2.31,;-1.33,-1.54,;,-2.31,;-5.33,-2.31,;-6.67,-1.54,;-8,-2.31,;-9.34,-1.54,;-8,-3.85,;-6.67,-4.62,;-5.33,-3.85,;-4,-4.62,;-2.67,-5.39,;1.33,4.62,;2.67,5.39,)| Show InChI InChI=1S/C30H30ClN3O6/c1-39-23-11-3-18(4-12-23)13-26(29(36)33-22-9-6-19(7-10-22)30(37)38)34-17-27(40-2)25(15-28(34)35)24-14-21(31)8-5-20(24)16-32/h5-10,14-15,17-18,23,26H,3-4,11-13H2,1-2H3,(H,33,36)(H,37,38)/t18-,23-,26? | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
BAYER PHARMA AKTIENGESELLSCHAFT
US Patent
| Assay Description
Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000 μM to 0.0078 μM; resulting final con... |
US Patent US9822102 (2017)
BindingDB Entry DOI: 10.7270/Q2FN18G5 |
More data for this
Ligand-Target Pair | |
Coagulation factor XI
(Homo sapiens (Human)) | BDBM246249
(US10183932, Example 157 | US9434690, 155 | US94346...)Show SMILES CO[C@H]1CC[C@H](CC(C(=O)Nc2ccc(cc2)C(O)=O)n2cc(OC)c(cc2=O)-c2cc(Cl)ccc2C#N)CC1 |r,wU:2.1,wD:5.5,(6.67,4.62,;5.33,5.39,;4,4.62,;4,3.08,;2.67,2.31,;1.33,3.08,;,2.31,;,.77,;1.33,,;1.33,-1.54,;2.67,.77,;4,,;4,-1.54,;5.33,-2.31,;6.67,-1.54,;6.67,,;5.33,.77,;8,-2.31,;9.34,-1.54,;8,-3.85,;-1.33,,;-2.67,.77,;-4,,;-5.33,.77,;-6.67,,;-4,-1.54,;-2.67,-2.31,;-1.33,-1.54,;,-2.31,;-5.33,-2.31,;-6.67,-1.54,;-8,-2.31,;-9.34,-1.54,;-8,-3.85,;-6.67,-4.62,;-5.33,-3.85,;-4,-4.62,;-2.67,-5.39,;1.33,4.62,;2.67,5.39,)| Show InChI InChI=1S/C30H30ClN3O6/c1-39-23-11-3-18(4-12-23)13-26(29(36)33-22-9-6-19(7-10-22)30(37)38)34-17-27(40-2)25(15-28(34)35)24-14-21(31)8-5-20(24)16-32/h5-10,14-15,17-18,23,26H,3-4,11-13H2,1-2H3,(H,33,36)(H,37,38)/t18-,23-,26? | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 2 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Bayer Pharma Aktiengesellschaft
US Patent
| Assay Description
Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000 μM to 0.0078 μM; resulting final con... |
US Patent US9434690 (2016)
BindingDB Entry DOI: 10.7270/Q2K936FF |
More data for this
Ligand-Target Pair | |
Coagulation factor XI
(Homo sapiens (Human)) | BDBM246249
(US10183932, Example 157 | US9434690, 155 | US94346...)Show SMILES CO[C@H]1CC[C@H](CC(C(=O)Nc2ccc(cc2)C(O)=O)n2cc(OC)c(cc2=O)-c2cc(Cl)ccc2C#N)CC1 |r,wU:2.1,wD:5.5,(6.67,4.62,;5.33,5.39,;4,4.62,;4,3.08,;2.67,2.31,;1.33,3.08,;,2.31,;,.77,;1.33,,;1.33,-1.54,;2.67,.77,;4,,;4,-1.54,;5.33,-2.31,;6.67,-1.54,;6.67,,;5.33,.77,;8,-2.31,;9.34,-1.54,;8,-3.85,;-1.33,,;-2.67,.77,;-4,,;-5.33,.77,;-6.67,,;-4,-1.54,;-2.67,-2.31,;-1.33,-1.54,;,-2.31,;-5.33,-2.31,;-6.67,-1.54,;-8,-2.31,;-9.34,-1.54,;-8,-3.85,;-6.67,-4.62,;-5.33,-3.85,;-4,-4.62,;-2.67,-5.39,;1.33,4.62,;2.67,5.39,)| Show InChI InChI=1S/C30H30ClN3O6/c1-39-23-11-3-18(4-12-23)13-26(29(36)33-22-9-6-19(7-10-22)30(37)38)34-17-27(40-2)25(15-28(34)35)24-14-21(31)8-5-20(24)16-32/h5-10,14-15,17-18,23,26H,3-4,11-13H2,1-2H3,(H,33,36)(H,37,38)/t18-,23-,26? | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 5.20 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft
US Patent
| Assay Description
To determine the factor XIa inhibition of the substances according to the invention, a biochemical test system is used which utilizes the reaction of... |
US Patent US10183932 (2019)
BindingDB Entry DOI: 10.7270/Q23T9K99 |
More data for this
Ligand-Target Pair | |
Coagulation factor XI
(Homo sapiens (Human)) | BDBM246249
(US10183932, Example 157 | US9434690, 155 | US94346...)Show SMILES CO[C@H]1CC[C@H](CC(C(=O)Nc2ccc(cc2)C(O)=O)n2cc(OC)c(cc2=O)-c2cc(Cl)ccc2C#N)CC1 |r,wU:2.1,wD:5.5,(6.67,4.62,;5.33,5.39,;4,4.62,;4,3.08,;2.67,2.31,;1.33,3.08,;,2.31,;,.77,;1.33,,;1.33,-1.54,;2.67,.77,;4,,;4,-1.54,;5.33,-2.31,;6.67,-1.54,;6.67,,;5.33,.77,;8,-2.31,;9.34,-1.54,;8,-3.85,;-1.33,,;-2.67,.77,;-4,,;-5.33,.77,;-6.67,,;-4,-1.54,;-2.67,-2.31,;-1.33,-1.54,;,-2.31,;-5.33,-2.31,;-6.67,-1.54,;-8,-2.31,;-9.34,-1.54,;-8,-3.85,;-6.67,-4.62,;-5.33,-3.85,;-4,-4.62,;-2.67,-5.39,;1.33,4.62,;2.67,5.39,)| Show InChI InChI=1S/C30H30ClN3O6/c1-39-23-11-3-18(4-12-23)13-26(29(36)33-22-9-6-19(7-10-22)30(37)38)34-17-27(40-2)25(15-28(34)35)24-14-21(31)8-5-20(24)16-32/h5-10,14-15,17-18,23,26H,3-4,11-13H2,1-2H3,(H,33,36)(H,37,38)/t18-,23-,26? | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 10 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft
US Patent
| Assay Description
To determine the factor XIa inhibition of the substances according to the invention, a biochemical test system is used which utilizes the reaction of... |
US Patent US10183932 (2019)
BindingDB Entry DOI: 10.7270/Q23T9K99 |
More data for this
Ligand-Target Pair | |
Coagulation factor XI
(Homo sapiens (Human)) | BDBM246249
(US10183932, Example 157 | US9434690, 155 | US94346...)Show SMILES CO[C@H]1CC[C@H](CC(C(=O)Nc2ccc(cc2)C(O)=O)n2cc(OC)c(cc2=O)-c2cc(Cl)ccc2C#N)CC1 |r,wU:2.1,wD:5.5,(6.67,4.62,;5.33,5.39,;4,4.62,;4,3.08,;2.67,2.31,;1.33,3.08,;,2.31,;,.77,;1.33,,;1.33,-1.54,;2.67,.77,;4,,;4,-1.54,;5.33,-2.31,;6.67,-1.54,;6.67,,;5.33,.77,;8,-2.31,;9.34,-1.54,;8,-3.85,;-1.33,,;-2.67,.77,;-4,,;-5.33,.77,;-6.67,,;-4,-1.54,;-2.67,-2.31,;-1.33,-1.54,;,-2.31,;-5.33,-2.31,;-6.67,-1.54,;-8,-2.31,;-9.34,-1.54,;-8,-3.85,;-6.67,-4.62,;-5.33,-3.85,;-4,-4.62,;-2.67,-5.39,;1.33,4.62,;2.67,5.39,)| Show InChI InChI=1S/C30H30ClN3O6/c1-39-23-11-3-18(4-12-23)13-26(29(36)33-22-9-6-19(7-10-22)30(37)38)34-17-27(40-2)25(15-28(34)35)24-14-21(31)8-5-20(24)16-32/h5-10,14-15,17-18,23,26H,3-4,11-13H2,1-2H3,(H,33,36)(H,37,38)/t18-,23-,26? | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft
US Patent
| Assay Description
To determine the factor XIa inhibition of the substances according to the invention, a biochemical test system is used which utilizes the reaction of... |
US Patent US10183932 (2019)
BindingDB Entry DOI: 10.7270/Q23T9K99 |
More data for this
Ligand-Target Pair | |
Coagulation factor XI
(Homo sapiens (Human)) | BDBM246249
(US10183932, Example 157 | US9434690, 155 | US94346...)Show SMILES CO[C@H]1CC[C@H](CC(C(=O)Nc2ccc(cc2)C(O)=O)n2cc(OC)c(cc2=O)-c2cc(Cl)ccc2C#N)CC1 |r,wU:2.1,wD:5.5,(6.67,4.62,;5.33,5.39,;4,4.62,;4,3.08,;2.67,2.31,;1.33,3.08,;,2.31,;,.77,;1.33,,;1.33,-1.54,;2.67,.77,;4,,;4,-1.54,;5.33,-2.31,;6.67,-1.54,;6.67,,;5.33,.77,;8,-2.31,;9.34,-1.54,;8,-3.85,;-1.33,,;-2.67,.77,;-4,,;-5.33,.77,;-6.67,,;-4,-1.54,;-2.67,-2.31,;-1.33,-1.54,;,-2.31,;-5.33,-2.31,;-6.67,-1.54,;-8,-2.31,;-9.34,-1.54,;-8,-3.85,;-6.67,-4.62,;-5.33,-3.85,;-4,-4.62,;-2.67,-5.39,;1.33,4.62,;2.67,5.39,)| Show InChI InChI=1S/C30H30ClN3O6/c1-39-23-11-3-18(4-12-23)13-26(29(36)33-22-9-6-19(7-10-22)30(37)38)34-17-27(40-2)25(15-28(34)35)24-14-21(31)8-5-20(24)16-32/h5-10,14-15,17-18,23,26H,3-4,11-13H2,1-2H3,(H,33,36)(H,37,38)/t18-,23-,26? | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
BAYER PHARMA AKTIENGESELLSCHAFT
US Patent
| Assay Description
Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000 μM to 0.0078 μM; resulting final con... |
US Patent US9822102 (2017)
BindingDB Entry DOI: 10.7270/Q2FN18G5 |
More data for this
Ligand-Target Pair | |
Coagulation factor XI
(Homo sapiens (Human)) | BDBM246249
(US10183932, Example 157 | US9434690, 155 | US94346...)Show SMILES CO[C@H]1CC[C@H](CC(C(=O)Nc2ccc(cc2)C(O)=O)n2cc(OC)c(cc2=O)-c2cc(Cl)ccc2C#N)CC1 |r,wU:2.1,wD:5.5,(6.67,4.62,;5.33,5.39,;4,4.62,;4,3.08,;2.67,2.31,;1.33,3.08,;,2.31,;,.77,;1.33,,;1.33,-1.54,;2.67,.77,;4,,;4,-1.54,;5.33,-2.31,;6.67,-1.54,;6.67,,;5.33,.77,;8,-2.31,;9.34,-1.54,;8,-3.85,;-1.33,,;-2.67,.77,;-4,,;-5.33,.77,;-6.67,,;-4,-1.54,;-2.67,-2.31,;-1.33,-1.54,;,-2.31,;-5.33,-2.31,;-6.67,-1.54,;-8,-2.31,;-9.34,-1.54,;-8,-3.85,;-6.67,-4.62,;-5.33,-3.85,;-4,-4.62,;-2.67,-5.39,;1.33,4.62,;2.67,5.39,)| Show InChI InChI=1S/C30H30ClN3O6/c1-39-23-11-3-18(4-12-23)13-26(29(36)33-22-9-6-19(7-10-22)30(37)38)34-17-27(40-2)25(15-28(34)35)24-14-21(31)8-5-20(24)16-32/h5-10,14-15,17-18,23,26H,3-4,11-13H2,1-2H3,(H,33,36)(H,37,38)/t18-,23-,26? | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Bayer Pharma Aktiengesellschaft
US Patent
| Assay Description
Test substances are dissolved in dimethyl sulphoxide and serially diluted in dimethyl sulphoxide (3000 μM to 0.0078 μM; resulting final con... |
US Patent US9434690 (2016)
BindingDB Entry DOI: 10.7270/Q2K936FF |
More data for this
Ligand-Target Pair | |
Search and Browse
